159 related articles for article (PubMed ID: 33581319)
1. N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment.
Boyaval F; van Zeijl R; Dalebout H; Holst S; van Pelt G; Fariña-Sarasqueta A; Mesker W; Tollenaar R; Morreau H; Wuhrer M; Heijs B
Mol Cell Proteomics; 2021; 20():100057. PubMed ID: 33581319
[TBL] [Abstract][Full Text] [Related]
2. N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
[TBL] [Abstract][Full Text] [Related]
3. N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.
Kaprio T; Satomaa T; Heiskanen A; Hokke CH; Deelder AM; Mustonen H; Hagström J; Carpen O; Saarinen J; Haglund C
Mol Cell Proteomics; 2015 Feb; 14(2):277-88. PubMed ID: 25452313
[TBL] [Abstract][Full Text] [Related]
4. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells.
Misonou Y; Shida K; Korekane H; Seki Y; Noura S; Ohue M; Miyamoto Y
J Proteome Res; 2009 Jun; 8(6):2990-3005. PubMed ID: 19292502
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
7. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
8. Spatial N-glycomics of the normal breast microenvironment reveals fucosylated and high-mannose N-glycan signatures related to BI-RADS density and ancestry.
Rujchanarong D; Spruill L; Sandusky GE; Park Y; Mehta AS; Drake RR; Ford ME; Nakshatri H; Angel PM
Glycobiology; 2024 Jun; 34(8):. PubMed ID: 38869882
[TBL] [Abstract][Full Text] [Related]
9. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
10. N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines.
Holst S; Wilding JL; Koprowska K; Rombouts Y; Wuhrer M
Cells; 2019 Mar; 8(3):. PubMed ID: 30909444
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation characteristics of colorectal cancer.
Holst S; Wuhrer M; Rombouts Y
Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis.
Ščupáková K; Adelaja OT; Balluff B; Ayyappan V; Tressler CM; Jenkinson NM; Claes BS; Bowman AP; Cimino-Mathews AM; White MJ; Argani P; Heeren RM; Glunde K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34752419
[TBL] [Abstract][Full Text] [Related]
14. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
15. In-Depth Analysis of the
Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
[TBL] [Abstract][Full Text] [Related]
16. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.
Zhang D; Xie Q; Wang Q; Wang Y; Miao J; Li L; Zhang T; Cao X; Li Y
Glycobiology; 2019 May; 29(5):372-384. PubMed ID: 30698702
[TBL] [Abstract][Full Text] [Related]
18. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.
Chik JH; Zhou J; Moh ES; Christopherson R; Clarke SJ; Molloy MP; Packer NH
J Proteomics; 2014 Aug; 108():146-62. PubMed ID: 24840470
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
